Gabriella Miller Kids First Research Act 2.0
This bill directs certain penalties assessed by the Securities Exchange Commission against pharmaceutical companies for specified violations to the 10-Year Pediatric Research Initiative Fund, an existing fund that supports pediatric disease research. In making allocations from that fund, the National Institutes of Health shall prioritize pediatric research that does not duplicate existing research activities.
[Congressional Bills 116th Congress]
[From the U.S. Government Publishing Office]
[H.R. 6556 Introduced in House (IH)]
<DOC>
116th CONGRESS
2d Session
H. R. 6556
To require certain civil penalties to be transferred to a fund through
which amounts are made available for the Gabriella Miller Kids First
Pediatric Research Program at the National Institutes of Health, and
for other purposes.
_______________________________________________________________________
IN THE HOUSE OF REPRESENTATIVES
April 17, 2020
Ms. Wexton (for herself, Mr. Cole, Mr. Welch, and Mr. Bilirakis)
introduced the following bill; which was referred to the Committee on
Energy and Commerce, and in addition to the Committee on Financial
Services, for a period to be subsequently determined by the Speaker, in
each case for consideration of such provisions as fall within the
jurisdiction of the committee concerned
_______________________________________________________________________
A BILL
To require certain civil penalties to be transferred to a fund through
which amounts are made available for the Gabriella Miller Kids First
Pediatric Research Program at the National Institutes of Health, and
for other purposes.
Be it enacted by the Senate and House of Representatives of the
United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the ``Gabriella Miller Kids First Research
Act 2.0''.
SEC. 2. TRANSFER OF FUNDS TO THE 10-YEAR PEDIATRIC RESEARCH INITIATIVE.
Section 30A of the Securities Exchange Act of 1934 (15 U.S.C. 78dd-
1) is amended by adding at the end the following:
``(h) Transfer of Amounts.--
``(1) In general.--With respect to civil monetary
sanctions, including penalties, disgorgement, and interest,
recovered under this section, section 13(b)(2), or section
32(c) from persons registered under section 510(b)(1) or
section 510(i)(1)(A)(i) of the Federal Food, Drug, and Cosmetic
Act, the Secretary of the Treasury shall transfer to the 10-
Year Pediatric Research Initiative Fund described in section
9008(i)(2) of the Internal Revenue Code of 1986 (the `Fund'),
an amount equal to the sum of all such sanctions.
``(2) Exception for funds to be paid to harmed investors.--
Paragraph (1) shall not apply to any monetary sanction
collected by the Commission in any judicial or administrative
action brought by the Commission under the securities laws that
is added to a disgorgement fund or other fund under section 308
of the Sarbanes-Oxley Act of 2002 (15 U.S.C. 7246) or otherwise
distributed to victims of a violation of the securities laws,
or the rules and regulations thereunder.
``(3) Application.--Amounts transferred to the Fund under
this subsection shall--
``(A) be transferred in the manner described under
section 9601 of the Internal Revenue Code of 1986; and
``(B) be available as described in section
9008(i)(2) of such Code.''.
SEC. 3. FUNDING FOR THE 10-YEAR PEDIATRIC RESEARCH INITIATIVE.
Section 402A(a)(2) of the Public Health Service Act (42 U.S.C.
282a(a)(2)) is amended by inserting before the period the following:
``, and amounts transferred into the 10-Year Pediatric Research
Initiative Fund under section 30A(h) of the Securities Exchange Act of
1934''.
SEC. 4. COORDINATION OF NIH FUNDING FOR PEDIATRIC RESEARCH.
(a) Sense of Congress.--It is the sense of the Congress that the
Director of the National Institutes of Health should oversee and
coordinate research that is conducted or supported by the National
Institutes of Health for research on pediatric cancer and other
pediatric diseases and conditions, including through the 10-Year
Pediatric Research Initiative Fund.
(b) Avoiding Duplication.--Section 402(b)(7)(B)(ii) of the Public
Health Service Act (42 U.S.C. 282(b)(7)(B)(ii)) is amended by inserting
``and shall prioritize such pediatric research that does not duplicate
existing research activities of the National Institutes of Health''
before ``; and''.
<all>
Introduced in House
Introduced in House
Sponsor introductory remarks on measure. (CR E373)
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Llama 3.2 · runs locally in your browser
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line